Herceptin® could potentially be delivered via a standard injection

[News]

A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published Online First in The Lancet Oncology.

More... (http://www.news-medical.net/news/20120809/Herceptinc2ae-could-potentially-be-delivered-via-a-standard-injection.aspx)